Open Access Pre-publication history

Second-line Treatment of Stage III/IV Non-Small-Cell Lung Cancer (NSCLC) with pemetrexed in routine clinical practice: Evaluation of performance status and health-related quality of life

Wolfgang Schuette, Hans Tesch, Hartwig Büttner, Thomas Krause, Victoria Soldatenkova and Clemens Stoffregen*

BMC Cancer 2012, 12:14  doi:10.1186/1471-2407-12-14

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 08 Jun 2011
Reviewer's Report alessandra bearz 29 Jul 2011
Reviewer's Report David Spigel 31 Oct 2011
Resubmission - Version 2 Manuscript Author's comment 06 Dec 2011
Resubmission - Version 3 Manuscript Author's comment 12 Dec 2011
Editorial acceptance 13 Dec 2011
Published 13 Jan 2012